𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tissue pharmacokinetics of fleroxacin in humans as determined by positron emission tomography

✍ Scribed by Rubin, Robert H.; Livni, E.; Babich, John; Alpert, Nathaniel M.; Liu, Yu-Ying; Cleeland, Roy; Prosser, Barbara La T.; Thom, Edna; Fischman, Alan J.

Book ID
121940835
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
540 KB
Volume
4
Category
Article
ISSN
0924-8579

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics of radiotracers in huma
Pharmacokinetics of radiotracers in human plasma during positron emission tomography
✍ Paul Cumming; Fuji Yokoi; Anjing Chen; Paul Deep; Alain Dagher; David Reutens; F πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 2 views

Many radiopharmaceuticals for positron emission tomography (PET) are substantially metabolized in peripheral organs. Pharmacological treatments intended to alter cerebral metabolism might also alter radiotracer metabolism, consequently altering the cerebral uptake. First-order rate constants for the

Regional cortical dysfunction in Alzheim
Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography
✍ Dr. Thomas N. Chase; Norman L. Foster; Paul Fedio; Rodney Brooks; Luigi Mansi; G πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 433 KB πŸ‘ 2 views

Local cerebral glucose metabolism and psychometric function were compared in 17 patients with Alzheimer's disease and 5 healthy age-matched controls. Performance on tests of global intellectual function averaged 30 to 45% lower in the Alzheimer's group. Mean cortical glucose metabolism, as determine